Mantiero, M.; Bini, M.; Polignano, M.; Porcu, L.; Sanfilippo, R.; Fabbroni, C.; Parma, G.; Lapresa, M.; Calidona, C.; Silvestri, C.;
et al. A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety. Cancers 2024, 16, 192.
https://doi.org/10.3390/cancers16010192
AMA Style
Mantiero M, Bini M, Polignano M, Porcu L, Sanfilippo R, Fabbroni C, Parma G, Lapresa M, Calidona C, Silvestri C,
et al. A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety. Cancers. 2024; 16(1):192.
https://doi.org/10.3390/cancers16010192
Chicago/Turabian Style
Mantiero, Mara, Marta Bini, Maggie Polignano, Luca Porcu, Roberta Sanfilippo, Chiara Fabbroni, Gabriella Parma, Mariateresa Lapresa, Carmelo Calidona, Cecilia Silvestri,
and et al. 2024. "A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety" Cancers 16, no. 1: 192.
https://doi.org/10.3390/cancers16010192
APA Style
Mantiero, M., Bini, M., Polignano, M., Porcu, L., Sanfilippo, R., Fabbroni, C., Parma, G., Lapresa, M., Calidona, C., Silvestri, C., Franza, A., Raspagliesi, F., Colombo, N., & Ducceschi, M.
(2024). A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety. Cancers, 16(1), 192.
https://doi.org/10.3390/cancers16010192
